27.09.2021 13:00

Vivex Biologics, Inc. to Attend Annual North American Spine Society Meeting

Folgen
Werbung

MIAMI, Sept. 27, 2021 /PRNewswire/ -- Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatment options, will be attending the North American Spine Society's (NASS) 36th annual meeting at the Boston Convention and Exhibition Center from Sept. 29 to Oct. 2, 2021.

VIVEX Biologics Logo (PRNewsfoto/VIVEX Biologics)

NASS 2021 brings together spine care professionals from across the nation with the world's largest technical exhibitions, technique demonstrations, abstract presentations, and hands-on education sessions. VIVEX team leaders will host technical exhibition #1322 at Hall AB during the exhibit days:

  • Wednesday, Sept. 29: 9 a.m.5 p.m.
  • Thursday, Sept. 30: 9 a.m.5 p.m.
  • Friday, Oct.1: 9 a.m.1:30 p.m.

Representatives from VIVEX will be at the conference to showcase their suite of spinal procedure solutions, as well as highlight two of their newest products, VIA Form+™ and VIA Disc® NP.

"We look forward to engaging with top experts from around the globe at NASS 2021," said Peter Wehrly, CEO at Vivex Biologics, Inc. "VIVEX is dedicated to collaborating with industry leaders, like NASS, to educate, research, and advocate with healthcare providers who are dedicated to excellence in the field of spine care."

For more information on VIVEX and its advanced regenerative medicine solutions, please visit www.vivex.com.

About Vivex Biologics, Inc.

Vivex Biologics is a pioneer in regenerative medicine, specializing in the development of naturally sourced treatment options and solutions that improve clinical, surgical, and therapeutic patient care through innovation. With tissue damage resulting from a variety of diseases, direct injury or trauma, there is a significant need for advanced solutions. By leveraging the resources of the nation's oldest civilian tissue bank, VIVEX is channeling the body's inherent healing qualities to bring patients optimal care and to provide medical professionals and patients with innovative treatment options for a broad range of indications.

Media Contact:
rbb Communications
Rachel Gerardi
rachel.gerardi@rbbcommunications.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vivex-biologics-inc-to-attend-annual-north-american-spine-society-meeting-301385026.html

SOURCE Vivex Biologics, Inc.

Jetzt noch kostenlos anmelden!

Im B2B-Seminar am Montag um 11 Uhr zeigen Ihnen die Investment-Experten Victoria Arnold und Dr. Manuel Bermes den neuen Anlagestandard in Krisenzeiten für mehr Rendite und Stabilität Ihres ETF-Portfolios.
Jetzt kostenlos anmelden!
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

US-Börsen letztlich uneins -- DAX geht stärker ins Wochenende -- Continental senkt Ausblick 2021 -- Snap enttäuscht Anleger -- Intel steigert Umsatz und Gewinn -- Evergrande, American Express im Fokus

Powell: Drosselung der Anleihekäufe sollte Mitte 2022 abgeschlossen sein. Goldman gewährt CEO Solomon und President Waldron einmaligen Bonus. Facebook schließt Lizenz-Vereinbarung mit französischen Verlagen. Honeywell senkt Umsatzprognose 2021. Schlumberger kehrt mit Wachstum deutlich in die Gewinnzone zurück. Siemens Energy zieht sich aus Wasserkraft-JV mit Voith zurück.

Umfrage

Wo steht der DAX zum Jahresende?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln